Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL3038484 Target Snapshot

Histone deacetylase 3/NCoR1 · PROTEIN COMPLEX · Homo sapiens

84Compounds
29Assays
3Approved Drugs
95.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-13

Protein identity stays anchored to UniProt O15379. Use UniProt O15379 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt O15379 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-13
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Histone deacetylase 3/NCoR1 as ChEMBL target CHEMBL3038484, mapped to UniProt O15379. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Histone deacetylase 3/NCoR1
PROTEIN COMPLEX · Homo sapiens
As of 2026-09-13
ChEMBL target ID
CHEMBL3038484
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-13
www.ebi.ac.uk
UniProt accession
O15379
Histone deacetylase 3
UniProt accession via ChEMBL component mapping As of 2026-09-13
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-13
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Histone deacetylase 3/NCoR1 is the right protein anchor across sources, using UniProt O15379 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelHistone deacetylase 3
UniProt AccessionO15379
Component TypeProtein
Sequence Length428 aa

Histone deacetylase 3

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Histone deacetylase 3/NCoR1, mapped to UniProt O15379. ChEMBL maps the protein component as Histone deacetylase 3. Sequence length is 428 aa.

Mapped IDO15379
Review nameHistone deacetylase 3/NCoR1
OrganismHomo sapiens
Clinical Profile

Clinical Phase Distribution

3
Approved
1
Phase II
1
Phase I
Assay Mix

Activity Type Distribution

IC5084.0
KI11.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL4637689 10.15 IC50 0.07 Preclinical
CHEMBL4641682 10.06 IC50 0.087 Preclinical
CHEMBL343448 9.82 Ki 0.15 Approved
CHEMBL4634501 9.77 IC50 0.17 Preclinical
CHEMBL99 9.27 Ki 0.54 Preclinical
CHEMBL4170617 9.17 IC50 0.67 Preclinical
CHEMBL4644307 8.92 IC50 1.2 Preclinical
CHEMBL4647458 8.7 IC50 2.0 Preclinical
CHEMBL113537 8.52 IC50 3.0 Preclinical
CHEMBL4632775 8.51 IC50 3.1 Preclinical
Distribution

pChEMBL Value Distribution

3
5.0
4
5.5
7
6.0
17
6.5
14
7.0
19
7.5
5
8.0
4
8.5
2
9.0
2
9.5
pChEMBL
Approved Drugs

Approved Drugs

ROMIDEPSIN
CHEMBL343448
Approved 2009
VORINOSTAT
CHEMBL98
Approved 2006
Assay Landscape

Assay Landscape

29
Total Assays
73
Tested Compounds
1
Assay Types
Binding — 29 assays, 73 compounds
BAO Format Assays Compounds Avg pChEMBL
cell-based format 15 27 7.7
protein complex format 10 38 6.9
assay format 4 8 6.5

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine